Biotech strategy, regulation, and policy

I am interested in how biotech and pharma companies decide whether and how to develop new medicines in particular clinical areas. I study questions with practical relevance, where the answers will help industry professionals make smarter choices about how to balance cost, time, risk, and reward in drug R&D.

My interest in these sorts of questions stems from my work as an advisor to biopharma companies and investors. My recent research articles, whitepapers, and opinion pieces have focused on drug regulation, drug pricing, corporate and investor decision-making, and clinical trial strategy. (See here for details on these projects and others, and see here for more details on my professional background and expertise.)

I have spots available for students to work on various ongoing and planned projects in biopharma strategy, regulation, pricing, clinical development, and related areas. In most of these projects, students would analyze and extract information from published papers, regulatory documents, and other sources, while learning about the processes of drug development, regulation, and commercialization. The outputs would be similar to those in prior work (see above). Preference will be given to students who can commit to continuing work in the fall (10+ hours per week).